PALVELLA THERAPEUTICS INC (PVLA) Stock Income Statement
NASDAQ:PVLA - Nasdaq - US6979471090 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 42.81M | 25.90M | 31.42M | 29.32M | 46.28M | |||
| Operating Expenses | 58.65M | 69.38M | 83.25M | 63.24M | 73.44M | |||
| Research and Development | 41.80M | 52.98M | 66.66M | 46.53M | 55.00M | |||
| Selling, General, and Administrative Expenses | 16.85M | 16.39M | 16.59M | 16.71M | 18.44M | |||
| Operating Income | -15.84M | -43.47M | -51.83M | -33.92M | -27.16M | |||
| Interest Income/Expense | 1.85M | 721.00K | 4.00K | 511.00K | 1.71M | |||
| Other Income/Expense | 3.36M | 1.30M | 2.40M | -3.66M | -26.00K | |||
| Non Recurring Items | -13.91M | 8.17M | 3.69M | N/A | N/A | |||
| Income Before Taxes | -24.54M | -33.28M | -45.74M | -37.07M | -25.47M | |||
| Income Tax | N/A | N/A | 0.00 | 164.00K | 0.00 | |||
| Net Income | -24.54M | -33.28M | -45.74M | -37.23M | -28.30M | |||
| EBITDA | -13.94M | -40.70M | -49.37M | -31.61M | -26.52M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -21.80 | -35.89 | -56.69 | -54.67 | -44.72 | |||
| Non GAAP EPS | N/A | -36.00 | -55.37 | -54.40 | -44.00 | |||
| Statistics | ||||||||
| Profit Margin | -57.33% | -128.47% | -145.58% | -126.97% | -61.15% | |||
| Operating Profit Margin | -37.01% | -167.84% | -164.97% | -115.68% | -58.68% | |||
All data in USD